NCI Community Oncology Research Program - Protocol Summary
URCC 13059 - "A GERIATRIC ASSESSMENT INTERVENTION FOR PATIENTS AGED 70 AND OVER RECEIVING CHEMOTHERAPY FOR ADVANCED CANCER: REDUCING CHEMOTHERAPY TOXICITY IN OLDER ADULTS (GAP 70+)"
The summary below serves as a brief review of the treatment plan and eligibility for the protocol.
This summary is not intended to be used in place of the full eligibility & treatment information in the protocol.
Please contact NCORP-KC for complete protocol information.
Cancer Control Clinical Trial
CANCER TYPE: Any Site
RESEARCH BASE: URCC 13059
NCT NUMBER: 02054741
HIPPA FORM: DOWNLOAD HIPPA FORM
Consent Form: VIEW CONSENT FORM
Additional Consent Form: VIEW CONSENT FORM 2
Any solid tumor, Stg III-IV, age >=70, planned 1st-line chemo; Eval of Geriatric Asmt & recommendations in reducing chemo toxicity (Drs must sign a consent for their own study participation. Site may enroll pts after 1 investigator has been enrolled for the site.) DCP-001 Eligible
THIS TRIAL IS DCP-001 ELIGIBLE
1) All investigators must sign a consent for their own study participation via REDCap (§16.3) or on paper. Procedures are minimal risk & involve completing surveys (de-identified) & identifying study pts.
2) A site may enroll pts after 1 investigator has been enrolled for the site.
3) Pts may simultaneously be registered to URCC 13070 - "IMPROVING COMMUNICATION FOR CANCER TREATMENT: ADDRESSING CONCERNS OF OLDER CANCER PATIENTS AND CAREGIVERS".
Please contact NCORP-KC for the current full protocol.